However, in other studies, the authors described HNF-1β expression not only in clear cell adenocarcinoma, but also in other tumor types including serous, endometrioid and mucinous carcinoma, and most types of borderline tumors [8,20-22]. The gene discussed is HNF1B; the disease is clear cell adenocarcinoma.